- Trials with a EudraCT protocol (1,135)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (24)
1,135 result(s) found for: lung cancer.
Displaying page 1 of 57.
EudraCT Number: 2009-012607-26 | Sponsor Protocol Number: MIMEB | Start Date*: 2009-12-10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:University of Cologne | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: MIMEB - Molecular Imaging with erlotinib and bevacizumab. A Phase II Clinical Trial to Evaluate the Accuracy of FDG-/FLT-PET and DCE-MRI for Early Prediction of Non-Progression in Patients with Adv... | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Patients with Advanced Non Squamous Cell Non Small Cell Lung Cancer (NSCLC), first-line. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Completed) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-005245-37 | Sponsor Protocol Number: M06-880 | Start Date*: 2008-04-17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Abbott GmbH & Co. KG | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: An Open-Label, Randomized, Phase 2 Study of Efficacy and Tolerability of ABT-869 in Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: FR (Ongoing) SE (Prematurely Ended) GB (Prematurely Ended) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-003790-18 | Sponsor Protocol Number: N16HYP | Start Date*: 2017-04-28 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:The Netherlands Cancer Institute | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Feasibility trial on combination of platinum doublets and hypofractionated radiotherapy for locally-advanced stage and / or inoperable non-small cell lung carcinoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Locally advanced non-small cell lung carcinoma stage III or inoperable stage II | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000570-22 | Sponsor Protocol Number: 20060441 | Start Date*: 2008-01-07 | ||||||||||||||||||||||||||
Sponsor Name:Amgen Inc | ||||||||||||||||||||||||||||
Full Title: A Randomized, Double-Blind, Trial of AMG 745 or Placebo for the Treatment of Cachexia in Subjects with Non-Small Cell Lung Cancer | ||||||||||||||||||||||||||||
Medical condition: Muscle cachexia due to non-small cell lung cancer (NSCLC). | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Completed) SE (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-007696-16 | Sponsor Protocol Number: TOGA 0601 | Start Date*: 2008-06-02 | ||||||||||||||||
Sponsor Name:TOGA Thoracic Oncology Group Antwerp | ||||||||||||||||||
Full Title: Low molecular weight heparin in advanced non small cell lung cancer (NSCLC): a randomized open label phase III study evaluating the effect of enoxaparin (Clexane) on survival and symptom control in... | ||||||||||||||||||
Medical condition: Non Small Cell Lung Cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005614-29 | Sponsor Protocol Number: CC-486-NSCL-001 | Start Date*: 2015-11-19 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Celgene Corporation | ||||||||||||||||||||||||||||||||||||||
Full Title: A Phase 2 multicenter, randomized, placebo controlled, double-blind study to assess the safety and efficacy of CC-486 (oral azacitidine) in combination with pembrolizumab (MK-3475) versus pembroliz... | ||||||||||||||||||||||||||||||||||||||
Medical condition: Second-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC). | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Completed) FR (Ongoing) ES (Completed) GR (Ongoing) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-007107-32 | Sponsor Protocol Number: M10-301 | Start Date*: 2009-07-31 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Abbott GmbH & Co. KG | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A Phase 2 Randomized, Placebo-Controlled, Double-Blind Study of Carboplatin /Paclitaxel in Combination with ABT-869 Versus Carboplatin/Paclitaxel Alone in Subjects with Advanced or Metastatic Non-S... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Non small cell lung cancer. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: CZ (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-000760-18 | Sponsor Protocol Number: 13.034 | Start Date*: 2014-11-24 | |||||||||||
Sponsor Name:Prof. Peter Licht | |||||||||||||
Full Title: Supplementary Epidural Analgesia in Video-Assisted Thoracic Surgery (VATS) - The SEAVATS Study. | |||||||||||||
Medical condition: Cancer pulmones | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003715-38 | Sponsor Protocol Number: D4190C00006 | Start Date*: 2016-05-12 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:MedImmune LLC | |||||||||||||||||||||||||||||||||||||||||||
Full Title: A Phase 1b Open-label Study to Evaluate the Safety and Tolerability of MEDI4736 in Combination with Tremelimumab in Subjects with Advanced Non-small Cell Lung Cancer | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: Locally advanced or metastatic squamous or nonsquamous non- small cell lung cancer (NSCLC) | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: BE (Ongoing) ES (Ongoing) DE (Prematurely Ended) GB (Ongoing) FR (Ongoing) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000659-23 | Sponsor Protocol Number: 220365-2017 | Start Date*: 2017-10-11 | ||||||||||||||||
Sponsor Name:Aarhus University Hospital | ||||||||||||||||||
Full Title: A Safety and feasibility study of standard dosing day 1 carboplatin AUC 5 every 3rd weeks with daily Navelbine® 20/30mg (oral) during 4 cycles (12 weeks) for the treatment of advanced NSCLC; A feas... | ||||||||||||||||||
Medical condition: Patients with metastatic or locally advanced Non-small-cell lung cancer (NSCLC) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002539-25 | Sponsor Protocol Number: ATOM 019 | Start Date*: 2004-12-10 | |||||||||||
Sponsor Name:UNIVERSITA' DEGLI STUDI DI UDINE | |||||||||||||
Full Title: Randomized phase II trial of second-line chemotherapy with oxaliplatin and docetaxel vs. docetaxel in patients with advanced non-small cell lung cancer (NSCLC) | |||||||||||||
Medical condition: Second-line chemotherapy in advanced non small cell lung cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005294-35 | Sponsor Protocol Number: ELDERLY-NEXT | Start Date*: 2009-02-26 | ||||||||||||||||||||||||||
Sponsor Name:AZIENDA USL 6 LIVORNO ZONA LIVORNESE | ||||||||||||||||||||||||||||
Full Title: Multicenter Phase II study of Sequential Chemotherapy with Cisplatin/Gemcitabine Followed by Docetaxel in Elderly Advanced Non-Small-Cell Lung Cancer (NSCLC) patients | ||||||||||||||||||||||||||||
Medical condition: elderly advanced NSCLC patients | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000104-42 | Sponsor Protocol Number: U31287-A-U201E | Start Date*: 2013-06-14 | |||||||||||||||||||||
Sponsor Name:DAIICHI SANKYO DEVELOPMENT LTD. | |||||||||||||||||||||||
Full Title: Open-label, Non-randomized Study of U3-1287 in Combination with Erlotinib in Subjects with Advanced Non-Small Cell Lung Cancer (NSCLC) - Extension | |||||||||||||||||||||||
Medical condition: Treatment for advanced or metastatic NSCLC in combination with erlotinib in subjects who are epidermal growth factor receptor (EGFR) treatment naïve after failure of at least one prior chemotherapy... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-006914-62 | Sponsor Protocol Number: BAY 43-9006 / 13266 | Start Date*: 2009-04-23 | |||||||||||||||||||||
Sponsor Name:Bayer HealthCare AG, 51368 Leverkusen, Germany | |||||||||||||||||||||||
Full Title: A Phase III, multi-center, placebo–controlled trial of Sorafenib (BAY 43-9006) in patients with relapsed or refractory advanced predominantly non squamous Non-Small Cell Lung Cancer (NSCLC) after 2... | |||||||||||||||||||||||
Medical condition: Non-small cell lung carcinoma in patients with predominantly non-squamous cell carcinoma histology | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Ongoing) BE (Completed) DE (Completed) AT (Completed) SE (Completed) ES (Completed) FR (Ongoing) BG (Completed) HU (Completed) GR (Completed) IT (Completed) GB (Ongoing) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-000711-85 | Sponsor Protocol Number: MEF4984g | Start Date*: 2011-10-17 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Genentech, Inc | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE SAFETY AND EFFICACY OF MEGF0444A IN COMBINATION WITH CARBOPLATIN, PACLITAXEL AND BEVACIZUMAB IN PATIENTS ... | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: ADVANCED OR RECURRENT NON-SQUAMOUS NON-SMALL CELL LUNG CANCER WHO HAVE NOT RECEIVED PRIOR CHEMOTHERAPY FOR ADVANCED DISEASE | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: CZ (Prematurely Ended) HU (Prematurely Ended) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-003690-40 | Sponsor Protocol Number: 944/08 | Start Date*: 2008-06-16 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: Low-doses radiotherapy and concomitant chemotherapy with pemetrexed in progression desease NSCLC: a dose-descalation phase II study | |||||||||||||
Medical condition: advanced and/or metastatic NSCLC | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005942-22 | Sponsor Protocol Number: MK8669-021 | Start Date*: 2009-01-15 | |||||||||||
Sponsor Name:MERCK & CO., INC. | |||||||||||||
Full Title: A Randomized Discontinuation Phase II Trial of Deforolimus in Non-Small Cell Lung Cancer (NSCLC) Patients with KRAS Mutations. | |||||||||||||
Medical condition: Non-Small Cell Lung Cancer (NSCLC) Patients with KRAS Mutations | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) ES (Prematurely Ended) DE (Prematurely Ended) DK (Completed) FR (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-001077-14 | Sponsor Protocol Number: 1200.217 | Start Date*: 2014-12-17 | ||||||||||||||||||||||||||
Sponsor Name:Boehringer Ingelheim RCV GmbH & Co KG | ||||||||||||||||||||||||||||
Full Title: An open label, single-arm phase IV study to assess the efficacy and safety of afatinib as second-line therapy for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) har... | ||||||||||||||||||||||||||||
Medical condition: Metastatic non-small cell lung cancer harbouring an EGFR mutation (Del 19 or L858R) | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: RO (Ongoing) PL (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-005631-97 | Sponsor Protocol Number: CAPPA-2 (PS-2) | Start Date*: 2007-11-26 | |||||||||||
Sponsor Name:ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - FONDAZIONE "G. PASCALE" | |||||||||||||
Full Title: | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-005020-42 | Sponsor Protocol Number: M11-089 | Start Date*: 2014-05-15 | |||||||||||
Sponsor Name:Abbvie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: Randomized, Double-Blind, Multicenter, Phase 3 Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastati... | |||||||||||||
Medical condition: Advanced or Metastatic Squamous Non-Small-Cell Lung Cancer (NSCLC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Ongoing) FI (Ongoing) LT (Completed) CZ (Ongoing) PT (Ongoing) HU (Ongoing) NO (Ongoing) SE (Ongoing) DE (Completed) AT (Completed) IT (Ongoing) IE (Ongoing) DK (Completed) NL (Ongoing) ES (Ongoing) GR (Ongoing) LV (Ongoing) PL (Ongoing) FR (Ongoing) HR (Ongoing) EE (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
